Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.78 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.60 |
| ▸ | MAOA | P21397 | 2/20 | 0.59 |
| ▸ | MAOB | P27338 | 2/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3071526 | 0.98 | CHRM2 (0.81) | CHRM2SIRT2MAOAMAOBALOX15 | |
| SCHEMBL284677 | 0.98 | CHRM2 (0.81) | CHRM2SIRT2MAOAMAOBALOX15 | |
| Hydrochloric Acid SCHEMBL3626828 | 0.96 | CHRM2 (0.79) | CHRM2SIRT2MAOAMAOBALOX15 | |
| Hydrochloric Acid SCHEMBL9702944 | 0.96 | CHRM2 (0.79) | CHRM2SIRT2MAOAMAOBALOX15 | |
| SCHEMBL9777412 | 0.96 | CHRM2 (0.79) | CHRM2SIRT2MAOAMAOBALOX15 | |
| SCHEMBL9188072 | 0.92 | CHRM2 (0.86) | CHRM2SIRT2MAOAMAOBALOX15 | |
| SCHEMBL6231722 | 0.91 | CHRM2 (0.85) | CHRM2SIRT2MAOAMAOBALOX15 | |
| SCHEMBL16741961 | 0.91 | CHRM2 (0.92) | CHRM2SIRT2MAOAMAOBALOX15 | |
| SCHEMBL29438821 | 0.91 | CHRM2 (0.70) | CHRM2SIRT2MAOAMAOBALOX15 | |
| SCHEMBL230222 | 0.91 | CHRM2 (0.70) | CHRM2SIRT2MAOAMAOBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3508473-B1 | METHOD FOR PRODUCING CARBAMIC ACID ESTER | AIST (JP) | 2021-05-26 | — | — | EP | claimed |
| US-10752579-B2 | Production method of carbamic acid ester | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2020-08-25 | — | — | US | claimed |
| EP-3672643-A2 | MAGNETIC RESONANCE TOMOGRAPHY CONTRAST MEDIA, USE THEREOF FOR MEASURING TEMPERATURE AND METHOD FOR MEASURING TEMPERATURE | Christian-Albrechts-Universität zu Kiel (DE) | 2020-07-01 | — | — | EP | claimed |
| EP-3508473-A1 | METHOD FOR PRODUCING CARBAMIC ACID ESTER | National Institute of Advanced Industrial Science and Technology (JP) | 2019-07-10 | — | — | EP | claimed |
| US-20190185420-A1 | PRODUCTION METHOD OF CARBAMIC ACID ESTER | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2019-06-20 | — | — | US | claimed |
| US-5850086-A | Iron complexes for bleach activation and stereospecific oxidation | REGENTS OF THE UNIVERSITY OF MINNESOTA | 1998-12-15 | — | — | US | claimed |
| WO-1997048710-A1 | IRON COMPLEXES FOR BLEACH ACTIVATION AND STEREOSPECIFIC OXIDATION | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1997-12-24 | — | — | WO | claimed |
| US-12607637-B2 | Super-resolution morphology-correlated detection of labile zinc | UNIVERSITY OF CINCINNATI (US) | 2026-04-21 | — | — | US | disclosed |
| EP-4722190-A1 | SUSTAINABLE SYNTHESIS OF A TERPENYLAMINE IN THE PRESENCE OF AT LEAST ONE ZINC-BASED PRECURSOR | Nantes Université (FR) | 2026-04-08 | — | — | EP | disclosed |
| EP-4158338-B1 | SUPER-RESOLUTION MORPHOLOGY-CORRELATED DETECTION OF LABILE ZINC | UNIV CINCINNATI (US) | 2025-08-13 | — | — | EP | disclosed |
| CN-119462720-A | Aminophenoxy transition metal complex and preparation method and application thereof | 万华化学集团股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| EP-3426740-B1 | METHOD OF PREPARING AN OXIDATIVELY CURABLE COATING FORMULATION | MILLIKEN INDUSTRIALS LTD (GB) | 2024-09-11 | — | — | EP | disclosed |
| CN-116874414-A | Anionic and cationic p-type amino bisphenol oxy alkali metal complex, and preparation method and application thereof | 华东理工大学 | 2023-10-13 | — | — | CN | disclosed |
| EP-1008645-A1 | Detergent bleaching compositions | UNILEVER PLC (GB) | 2000-06-14 | — | — | EP | disclosed |
| US-5850086-A | Iron complexes for bleach activation and stereospecific oxidation | REGENTS OF THE UNIVERSITY OF MINNESOTA | 1998-12-15 | — | — | US | disclosed |
| WO-1997048710-A1 | IRON COMPLEXES FOR BLEACH ACTIVATION AND STEREOSPECIFIC OXIDATION | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1997-12-24 | — | — | WO | disclosed |
| EP-0755925-A1 | N,N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene-diamine derivatives and their use in pharmaceutical and cosmetic compositions | L'OREAL (FR) | 1997-01-29 | — | — | EP | disclosed |
| EP-0396435-B1 | Polyaza derivatives and their metal complexes for use in the fixation of oxygen | AIR LIQUIDE (FR) | 1995-06-21 | — | — | EP | disclosed |
| EP-0396435-A1 | Polyaza derivatives and their metal complexes for use in the fixation of oxygen | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 1990-11-07 | — | — | EP | disclosed |
| WO-1990009987-A1 | POLYNITROGENOUS DERIVATIVES AND THEIR METALLIC COMPLEXES WHICH CAN BE USED FOR OXYGEN FIXATION | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 1990-09-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12607637-B2 | Super-resolution morphology-correlated detection of labile zinc | SARAF, TFEB, CHERP | CHRM2 4387/4885SIRT2 936/4885MAOA 3729/4885 |
| US-20190185420-A1 | PRODUCTION METHOD OF CARBAMIC ACID ESTER | CA2, CA7, CA4 | CHRM2 174/4885SIRT2 570/4885MAOA 2769/4885 |
| US-10752579-B2 | Production method of carbamic acid ester | CA2, CA7, CA4 | CHRM2 174/4885SIRT2 570/4885MAOA 2769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.